Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. van der Eerden (Rotterdam, Netherlands), A. Pieters (Rotterdam, Netherlands), M. Bakker (Rotterdam, Netherlands), R. Hoek (Rotterdam, Netherlands), J. Altenburg (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands). The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise. 4953

Member's Comments

No comment yet.

Related content which might interest you: The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre Source: Eur Respir J, 53 (4) 1802081; 10.1183/13993003.02081-2018 Year: 2019 The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 Year: 2018 The clinical impact of nebulised antibiotics in adults with bronchiectasis and chronic pseudomonas aeruginosa Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Pseudomonas eradication management in COPD: results from a single centre Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021 Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology Source: Eur Respir J, 53 (3) 1802191; 10.1183/13993003.02191-2018 Year: 2019 Pseudomonas aeruginosa eradication therapy on Cystic Fibrosis- Guideline and clinical routine Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis Source: Eur Respir J , 49 (4)  1600851; DOI: 10.1183/13993003.00851-2016 Year: 2017 Eradication of pseudomonas aeruginosa in paediatric cystic fibrosis patients in Northern Ireland Source: Eur Respir J 2003; 22: Suppl. 45, 502s Year: 2003 DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Survey of microbiology, pseudomonas eradication and antimicrobial prophylaxis in adult patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006 Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006 Effect of long term treatment with azithromycin on clinical status and lung function parameters in cystic fibrosis patients colonised by pseudomonas aeruginosa Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers Source: Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017 Year: 2018